(USCAP – Workshop) Dr. Rimm on Phenotyping of IMC Data and Standardization of Ki67 Using Image Analysis
Please join Dr. David Rimm and Dr. Stine Harder at Visiopharm’s workshop at the USCAP Annual Meeting in Los Angeles.
Register here
This workshop is divided into two parts. In the first part, we focus on automatic phenotyping in the context of the tissue microenvironment presented by Keynote Speaker Dr. David Rimm.
Dr. Rimm’s lab has used the Visiopharm image analysis software for more traditional as well as novel methods in his lab. Imaging Mass Cytometry allows high-plex analysis but data from 30+ biomarkers on a single slide creates a challenge for analysis. Dr. Rimm’s lab has used Visiopharm’s Phenotype module to discover new methods to predict recurrence in patients treated with trastuzumab. In a second, more conventional effort, Dr.Rimm’s lab used Visiopharm software for image analysis for a new approach to standardization of Ki67 analysis between labs and operators. This approach will increase the clinical utility of Ki67.
In the second part, Visiopharm’s experts will outline our latest clinical development. We will explore Visiopharm’s approach to analyzing clinical data using Artificial Intelligence. Learn about the latest CE-IVD APP using AI for metastasis detection in lymph nodes for breast and colon cancer, which brings advanced Deep Learning into the hands of pathologists and transforms routine tasks with robust decision support.
Register here
Keynote speakers
David L. Rimm M.D.-Ph.D., Dept of Pathology, Yale University School of Medicine, New Haven
Dr. David Rimm is a Professor in the Departments of Pathology and Medicine (Oncology) at the Yale University School of Medicine. He is the Director of Yale Pathology Tissue Services. He also serves on the CAP Immunohistochemistry committee and multiple scientific advisory boards for biotech and pharma. He is an author of over 400 peer-reviewed papers and eight patents.
Stine Harder, Ph.D., Head of Clinical Product Management, Visiopharm
Dr. Stine Harder has a Ph.D. in Image Analysis from the Technical University of Denmark. Image analysis is her passion, and she continued her research during a 2-year postdoc tenure. She joined Visiopharm three years ago as an image analysis specialist but has recently been appointed Head of Clinical Product Management. In her current position, Stine oversees the complete lifecycle of Visiopharm’s clinical products.
When and where will I find the workshop?
The workshop is on March 4th, 2020 at 12 PM – at the USCAP Annual Meeting, Los Angeles Convention Center, Wes Hall Second Floor in the theater LACC 411.
Track: Pathobiology and Emerging Techniques
Additional Information
Please note entry to the workshop requires that you are an attendee of the USCAP 2020 Annual Meeting.
Lunch will be provided.
In US: Our CE-IVD APPs are for Research Use Only, not for use in diagnostic procedures.
Source: Visiopharm
